D-0472-2025 Class II Ongoing
FDA drug recall D-0472-2025 was initiated by Eugia US LLC on May 29, 2025 and is designated Class II. Reason for recall: Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis. The recall status is ongoing. Affected quantity: 48,000 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 25, 2025
- Initiation Date
- May 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 48,000 vials
Product description
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
Reason for recall
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Distribution pattern
Nationwide in the USA
Code information
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0472-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026